This talk highlights new advances in speaker diarization and automated speech recognition models that make it easier to track meaningful change in language and social communication.
This presentation will review the state of the science in developing biomarkers to guide clinical research and practice in autism.
This seminar will discuss a ‘mirror-opposite’ model of empathy, proposing a uniquely cognitive decrease for autism and a uniquely affective decrease for psychopathy, and whether CT or SA may be the more promising candidate for characterizing empathy and its correlates.
The lecture will review progress in precision health in NDDs, with focus on studies of early infant development, with improved precision in timing of diagnosis and intervention, and studies of clinical trial readiness in genetic neurodevelopmental disorders. The lecture also will discuss recent advocacy efforts in autism and child health, emphasizing the importance of messaging rigorous and evidence-based science and clinical care to the broader community.
Dr. Shafali S. Jeste, MD is a behavioral child neurologist and Chair of Pediatrics at UCLA David Geffen School of Medicine. Her research focuses on autism and related neurodevelopmental disorders, with an emphasis on identifying biomarkers and predictors of atypical brain development in infants and young children. Her work integrates neurophysiology, genetics, and behavioral assessments to enable earlier diagnosis and targeted interventions, particularly in genetic conditions associated with autism. Dr. Jeste has led multiple NIH-funded studies and clinical trials and has authored more than 150 peer-reviewed publications advancing precision medicine approaches for neurodevelopmental disorders.
